Summary of Henry Schein's Q1 2026 Earnings Call

1Key Financial Results and Metrics

Global Sales: $3.4 billion, up 6.3% year-over-year.

GAAP Operating Margin: 5.41%, down 12 basis points from the previous year.

Non-GAAP Operating Margin: 7.53%, up 28 basis points, driven by gross margin expansion.

GAAP Net Income: $107 million ($0.92 per diluted share), compared to $110 million ($0.88 per diluted share) in Q1 2025.

Non-GAAP Net Income: $153 million ($1.32 per diluted share), up from $143 million ($1.15 per diluted share) in the prior year.

Adjusted EBITDA: $289 million, an 11.6% increase from $259 million in Q1 2025.

Operating Cash Flow: Negative $97 million due to seasonal decreases in accounts payable.

2Strategic Updates and Business Highlights

BOLD+1 Strategy: Focus on enhancing operational execution and integrating technology to improve customer experience and efficiency.

Market Position: Strong competitive advantages in the dental market, with ongoing investments from Dental Service Organizations (DSOs) driving growth.

Product Development: Increased focus on AI solutions and technology integration, with successful launches at recent events.

Value Creation Initiatives: Targeting over $200 million in annual operating income improvement, with a $125 million run rate expected by the end of 2026.

E-commerce Expansion: Successful rollout of the global e-commerce platform, with over 80% of U.S. dental e-commerce sales now transacted online.

3Forward Guidance and Outlook

2026 Financial Guidance:

Total sales growth expected to be approximately 3% to 5%.

Non-GAAP diluted EPS projected between $5.23 and $5.37.

Adjusted EBITDA anticipated to grow in the mid-single digits.

Guidance assumes stable dental and medical end markets and mitigated impacts from rising oil prices.

4Challenges and Points of Concern

Medical Business Softness: Decline in demand for point-of-care diagnostic products due to a light flu season, impacting overall medical sales.

Rising Costs: Concerns about increasing oil prices affecting freight and product costs, although management is implementing measures to mitigate these impacts.

Market Dynamics: Competitive pressures from lower-priced entrants in the digital equipment market, which may affect margins.

5Notable Q&A Insights

Gross Margin Drivers: Improvements attributed to value creation initiatives and a dynamic pricing environment, with own brand products outpacing overall portfolio growth.

Specialty Products Growth: Expected to improve in subsequent quarters, with strong demand for value implants but flat performance in premium implants.

DSO Growth: DSOs are growing faster than the overall market, with Henry Schein positioned as a key partner due to its comprehensive support and technology offerings.

Customer Engagement: Management emphasizes the importance of maintaining strong relationships with customers, particularly when discussing price increases due to rising costs. Overall, Henry Schein reported a strong start to 2026, with solid sales growth and strategic initiatives aimed at enhancing operational efficiency and customer service, despite facing challenges in the medical segment and rising costs.